(Q34167753)

English

The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

The effects of lumiracoxib 100 mg once daily vs. ibuprofen 600 mg three times daily on the blood pressure profiles of hypertensive osteoarthritis patients taking different classes of antihypertensive agents (English)

1 reference

Europe PubMed Central

31 July 2017

0 references

author name string

T M MacDonald

1

1 reference

Europe PubMed Central

31 July 2017

D Richard

2

1 reference

Europe PubMed Central

31 July 2017

K Lheritier

3

1 reference

Europe PubMed Central

31 July 2017

G Krammer

4

1 reference

Europe PubMed Central

31 July 2017

publication date

1 May 2010

1 reference

Europe PubMed Central

31 July 2017

International Journal of Clinical Practice

1 reference

Europe PubMed Central

31 July 2017

64

1 reference

Europe PubMed Central

31 July 2017

6

1 reference

Europe PubMed Central

31 July 2017

746-755

1 reference

Europe PubMed Central

31 July 2017

Comparative cardiovascular safety of traditional nonsteroidal anti-inflammatory drugs

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Prevalence of cardiovascular disease risk factors among US adults with self-reported osteoarthritis: data from the Third National Health and Nutrition Examination Survey.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Effect of indomethacin on the antihypertensive efficacy of valsartan and lisinopril: a multicentre study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Rationale for fixed-dose combinations in the treatment of hypertension: the cycle repeats

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Effect of indomethacin on blood pressure lowering by captopril and losartan in hypertensive patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

The impact of ibuprofen on the efficacy of antihypertensive treatment with hydrochlorothiazide in elderly persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

5 July 2018

Interaction between antihypertensives and NSAIDs in primary care: a controlled trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Effect on blood pressure of lumiracoxib versus ibuprofen in patients with osteoarthritis and controlled hypertension: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Efficacy and tolerability of lumiracoxib in the treatment of osteoarthritis of the knee: a 13-week, randomized, double-blind comparison with celecoxib and placebo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Meta-analysis of cyclooxygenase-2 inhibitors and their effects on blood pressure

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Increased renal vascular sensitivity to angiotensin II in hypertension is due to decreased response to prostaglandins

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Effects of celecoxib and rofecoxib on blood pressure and edema in patients > or =65 years of age with systemic hypertension and osteoarthritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2948421

28 October 2018

Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of indomethacin on the renal response to angiotensin II receptor blockade in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effects of nonsteroidal anti-inflammatory drugs on blood pressures of patients with hypertension controlled by verapamil

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of blood pressure during treatment with naproxen or ibuprofen in hypertensive patients treated with hydrochlorothiazide

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of indomethacin, sulindac, naproxen, aspirin, and paracetamol in treated hypertensive patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/20518950

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1742-1241.2010.02346.X

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34167753&oldid=1946949514"